Brisbane, California, United States The main office of represented VC is situated in the South San Francisco. The company was established in North America in United States.
The typical case for the fund is to invest in rounds with 4 participants. Despite the DigiTx Partners, startups are often financed by Gobi Partners, Joyance Partners, Intel Capital. The meaningful sponsors for the fund in investment in the same round are Rethink Impact, Mayo Clinic, Joyance Partners. In the next rounds fund is usually obtained by XTX Ventures, Wavemaker Partners, Vasudev Bailey.
Considering the real fund results, this VC is 50 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is generally included in 2-6 deals every year. The important activity for fund was in 2017.
Among the most popular portfolio startups of the fund, we may highlight Siris Medical, Embr Labs, Tissue Analytics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Wearables, Information Technology.
Related Funds
| Fund Name | Location |
| Amazon Web Services | Seattle, United States, Washington |
| Blockchain Japan | - |
| Coent Venture Partners | Central, Central Region, Singapore |
| Covestco-Seteura | England, London, United Kingdom |
| Digital Healthcare Partners | - |
| Fathom Capital | California, San Francisco, United States |
| Grants4Apps Turkey | - |
| KBBO Group | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates |
| Kyorin | Japan, Tokyo |
| Lavrock Ventures | Mclean, United States, Virginia |
| NCE Ventures | China, Shanghai |
| New England Business Association (formerly Smaller Business Association of New England) | - |
| Qizhi Investment Management | China, Guangdong, Guangzhou |
| Shanghai Guomai Asset Management | China, Shanghai |
| Shenzhen Rapoo Technology | China, Guangdong, Shenzhen |
| Suzhou Kingswood Printing Ink | China, Jiangsu, Suzhou |
| The EuroMena Funds | Lebanon, New Hampshire, United States |
| U.S. Bancorp | Minneapolis, Minnesota, United States |
| Vintage Fund | California, Los Angeles, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CardioSignal | $10M | 23 Jan 2024 | Turku, Western Finland, Finland | ||
Ciba Health | $10M | 04 Dec 2023 | New York, New York, United States | ||
Tali AI | 08 Nov 2023 | Toronto, Ontario, Canada | |||
FIGUR8 | $25M | 08 Aug 2023 | Boston, Massachusetts, United States | ||
Mightier | $17M | 13 Dec 2021 | Boston, Massachusetts, United States | ||
Rune Labs | $22M | 16 Sep 2021 | San Francisco, California, United States | ||
Cleerly | $43M | 21 Jun 2021 | New York, New York, United States | ||
| $9M | 30 Mar 2021 | San Francisco, California, United States | |||
Eko | $65M | 09 Nov 2020 | Oakland, California, United States |
– Rune Labs is a San Francisco, CA-based brain data company enabling the advancement and delivery of precision neuroscience therapeutics.
– The company raised $22.8m in Series A funding.
– The round was led by Eclipse Ventures with participation from current investors including DigiTx Partners and Moment Ventures.
– The new investment will be used to expand the number of patients, clinicians, and researchers using its platform.
– Cleerly, a NYC-based company creating a new standard of care for heart disease, launched with $43m in Series B funding.
– The round was led by Vensana Capital with participation from LRVHealth, New Leaf Venture Partners, DigiTx Partners, the American College of Cardiology, Cigna Ventures, and existing investors.
– The company intends to use the funds to scale its commercial reach, expand operational capabilities and strategic partnerships, and continue to grow its focus on research and development.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CardioSignal | $10M | 23 Jan 2024 | Turku, Western Finland, Finland | ||
Ciba Health | $10M | 04 Dec 2023 | New York, New York, United States | ||
Tali AI | 08 Nov 2023 | Toronto, Ontario, Canada | |||
FIGUR8 | $25M | 08 Aug 2023 | Boston, Massachusetts, United States | ||
Mightier | $17M | 13 Dec 2021 | Boston, Massachusetts, United States | ||
Rune Labs | $22M | 16 Sep 2021 | San Francisco, California, United States | ||
Cleerly | $43M | 21 Jun 2021 | New York, New York, United States | ||
| $9M | 30 Mar 2021 | San Francisco, California, United States | |||
Eko | $65M | 09 Nov 2020 | Oakland, California, United States |
